In this week’s Solidarity Fridays episode, Joe Moore interviews CEO of MINDCURE, Kelsey Ramsden. She discusses iSTRYM, their app designed to use A.I. to examine real-time data from users and provide drug-agnostic insights and recommendations; and the Desire Project, in which they are researching MDMA to help combat Hypoactive Sexual Desire Disorder (HSDD), an affliction that leaves women unable to feel sexual desire. Joe and Kyle also discuss a recent issue with the Facebook group and a rather accusatory tweet, whether or not ketamine is addictive, the shortcomings of at-home ketamine therapy options, and if we should always be striving for the mystical in psychedelic experiences.

The post PTSF87 – Ketamine, Addiction, and Mysticism + Kelsey Ramsden of MINDCURE appeared first on Psychedelics Today.

Previous articleEditor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry
Next articleThe Wild World of 19th Century Psychedelics